Evidence map›Paper›PMID 26909308›Full record

ArticleMolecular metabolism2015

A human beta cell line with drug inducible excision of immortalizing transgenes.

Marion Benazra, Marie-José Lecomte, Claire Colace, Andreas Müller, Cécile Machado, Severine Pechberty, Emilie Bricout-Neveu, Maud Grenier-Godard, Michele Solimena, Raphaël Scharfmann and 2 more

Abstract read
In one paragraph

Article in Molecular metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Multiple genetic variants at the SLC30A8 locus affect local super-enhancer activity and influence pancreatic β-cell survival and function.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  19. Article
  20. Redox regulation of mNature cell biology · 2024
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marion BenazraInstitut du cerveau et de la moelle (ICM), Biotechnology & Biotherapy Team, 75013 Paris, France; CNRS UMR7225, 75013 Paris, France; INSERM U1127, 75013 Paris, France; Université Pierre et Marie Curie, 75013 Paris, France.
Marie-José LecomteEndocells, Pépinière d'entreprises Institut du Cerveau et de la Moelle, 75007 Paris, France.
Claire ColaceInstitut du cerveau et de la moelle (ICM), Biotechnology & Biotherapy Team, 75013 Paris, France; CNRS UMR7225, 75013 Paris, France; INSERM U1127, 75013 Paris, France; Université Pierre et Marie Curie, 75013 Paris, France.
Andreas MüllerPaul Langerhans Institute of the Helmholtz Center Munich at the University Hospital and Faculty of Medicine, TU Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V), 85764 Neuherberg, Germany.
Cécile MachadoEndocells, Pépinière d'entreprises Institut du Cerveau et de la Moelle, 75007 Paris, France.
Severine PechbertyEndocells, Pépinière d'entreprises Institut du Cerveau et de la Moelle, 75007 Paris, France.
Emilie Bricout-NeveuEndocells, Pépinière d'entreprises Institut du Cerveau et de la Moelle, 75007 Paris, France.
Maud Grenier-GodardEndocells, Pépinière d'entreprises Institut du Cerveau et de la Moelle, 75007 Paris, France.
Michele SolimenaPaul Langerhans Institute of the Helmholtz Center Munich at the University Hospital and Faculty of Medicine, TU Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V), 85764 Neuherberg, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Raphaël ScharfmannINSERM, U1016, Institut Cochin, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France.
Paul CzernichowEndocells, Pépinière d'entreprises Institut du Cerveau et de la Moelle, 75007 Paris, France.
Philippe RavassardInstitut du cerveau et de la moelle (ICM), Biotechnology & Biotherapy Team, 75013 Paris, France; CNRS UMR7225, 75013 Paris, France; INSERM U1127, 75013 Paris, France; Université Pierre et Marie Curie, 75013 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAccess to immortalized human pancreatic beta cell lines that are phenotypically close to genuine adult beta cells, represent a major tool to better understand human beta cell physiology and develop new therapeutics for Diabetes. Here we derived a new conditionally immortalized human beta cell line, EndoC-βH3 in which immortalizing transgene can be efficiently removed by simple addition of tamoxifen.

methodsWe used lentiviral mediated gene transfer to stably integrate a tamoxifen inducible form of CRE (CRE-ERT2) into the recently developed conditionally immortalized EndoC βH2 line. The resulting EndoC-βH3 line was characterized before and after tamoxifen treatment for cell proliferation, insulin content and insulin secretion.

resultsWe showed that EndoC-βH3 expressing CRE-ERT2 can be massively amplified in culture. We established an optimized tamoxifen treatment to efficiently excise the immortalizing transgenes resulting in proliferation arrest. In addition, insulin expression raised by 12 fold and insulin content increased by 23 fold reaching 2 μg of insulin per million cells. Such massive increase was accompanied by enhanced insulin secretion upon glucose stimulation. We further observed that tamoxifen treated cells maintained a stable function for 5 weeks in culture.

conclusionsEndoC βH3 cell line represents a powerful tool that allows, using a simple and efficient procedure, the massive production of functional non-proliferative human beta cells. Such cells are close to genuine human beta cells and maintain a stable phenotype for 5 weeks in culture.

Indexed as

Cell engineeringConditional immortalizationHuman beta cell functionHuman pancreatic beta cell lineTamoxifen inducible CRE

Identifiers

PMID26909308
PMCPMC4731729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.